None listed
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), Powai, Mumbai- 400 076
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex, aged 18-65 years both inclusive 2. Patients with P. vivax or P. falciparum parasitemia more than 1000 parasites/microliter 3. Those willing to provide written informed consent and comply with protocol requirements
Exclusion criteria
Exclusion criteria: 1. Patients with history of significant systemic diseases like autoimmune disorders, chronic liver diseases, psychiatric illness and bleeding disorders etc. as judged by history and physical examination. 2. Severe/complicated malaria as per WHO criteria 3. Subjects unwilling to consent for the study 4. Malaria patients having mixed infection (both P.vivax and P.falciparum) in peripheral smear
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the proteomics profile of P.vivax versus P. falciparum malariaTimepoint: 6 months;To obtain the global proteome profile of P. falciparum and P.vivaxTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr. Nithya Gogtay
Associate Professor
Outcome results
None listed